Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world's literature

Robert F Ritchie1, Glenn E Palomaki, Louis M Neveux

  • 1Foundation for Blood Research, Scarborough, Maine 04074, USA. ritchie@fbr.org

Insights

Establishing reliable reference intervals for serum complement proteins C3 and C4 is crucial for clinical use. This meta-analysis supports lifelong reference ranges, overcoming a key barrier in diagnosis and prognosis.

Area of Science:

  • Clinical Chemistry
  • Immunology
  • Biomarker Discovery

Background:

  • Serum complement protein (C3 and C4) measurements are vital for diagnosis and prognosis.
  • Current limitations in bedside use stem from a lack of credible reference materials and quantification methods.
  • Technological advancements have improved measurement capabilities, but reliable reference intervals across all ages remain a challenge.

Purpose of the Study:

  • To establish reliable, lifelong reference intervals for serum complement proteins C3 and C4 for both males and females.
  • To address the remaining barrier to cost-effective and relevant clinical use of serum protein data.
  • To provide a robust dataset supporting the use of established reference ranges in clinical practice.

Main Methods:

  • A meta-analysis of 51 publications reporting reference intervals for C3 and C4.
  • Statistical analysis of identified reference intervals meeting predefined criteria from prior studies.
  • Comparison of newly analyzed lifelong reference ranges with findings from previous smaller studies.

Main Results:

  • The meta-analysis statistically analyzed data from 51 publications.
  • Established lifelong reference ranges were found to agree with previous smaller studies.
  • The findings provide strong support for the proposed reference ranges.

Conclusions:

  • The study provides validated, lifelong reference intervals for serum C3 and C4.
  • These reference intervals are essential for accurate diagnosis and prognosis across all age groups.
  • The findings facilitate more relevant and cost-effective clinical application of complement protein testing.